UPDATE
: Monday, September 7, 2020
Home
Login
Mobile Version
All
Hospital
Pharma
Bio
Korea‘s Bio Industry
Device/ICT
Policy
People
Life science
Special
Innovation for Survival
Korea’s medical culture series
Korea’s New Candidate Drug Watch List
Special Series in Celebration of KBR's 1st Anniversary
Interview with foreign envoys
Special Series in Celebration of KBR’s 2nd Anniversary
Interview with global pharma
Special Series in Celebration of KBR’s 3rd Anniversary
Special Series in Celebration of KBR’s 4th Anniversary
ASCO 2020 Highlights
Opinion
Reporter’s Notebook
Search
트위터
페이스북
RSS
상단여백
제목보기
제목보기
제목+내용
Korea University Medicine aims highest level of healthcare
by Kim Yun-mi
2019-12-23 14:46
‘Blocking CGRP is key in migraine treatment’
by Kim Yun-mi
2019-12-19 12:15
CDK4/6+fulvestrant combo may get benefit in 1st half of 2020
by Kim Yun-mi
2019-12-17 11:59
Regulator finds harmful substances in liquid e-cigarettes
by Kim Yun-mi
2019-12-13 13:58
‘There should be no Invossa fiasco again’
by Kim Yun-mi
2019-12-11 15:03
라인
‘Lynparza raises value of precision medicine as anticancer treatment’
by Kim Yun-mi
2019-12-05 16:05
Regulator’s re-evaluation of cognitive enhancer to take time
by Kim Yun-mi
2019-11-27 12:07
Roche’s flu treatment Xofluza wins approval
by Kim Yun-mi
2019-11-26 16:08
Immunotherapies give hope for esophageal cancer patients
by Kim Yun-mi
2019-11-26 15:37
Drugmakers obliged to conduct impurity tests and report results
by Kim Yun-mi
2019-11-25 16:09
라인
Korea, Singapore to cooperate on GMP in pharmaceuticals
by Kim Yun-mi
2019-11-25 14:49
‘Korea's vaccine industry needs to grow to secure self-sufficiency’
by Kim Yun-mi
2019-11-25 11:55
Regulator bans 13 nizatidine drugs over carcinogenic risk
by Kim Yun-mi
2019-11-22 15:32
Regulator detects NDMA also in nizatidine drugs
by Kim Yun-mi
2019-11-21 10:53
‘Japan much advanced than Korea in ALK-positive NSCLC treatment’
by Kim Yun-mi
2019-11-20 16:16
라인
Will Biogen be 1st to get FDA nod for Alzheimer’s drug?
by Kim Yun-mi
2019-11-14 11:23
‘Generic drugs must indicate ingredient names on label’
by Kim Yun-mi
2019-11-13 15:51
Sanofi’s DPT vaccine in shortage in some parts of Korea
by Kim Yun-mi
2019-11-11 15:27
Takeda’s labor turmoil goes to extremes amid rumored unit sell-off
by Kim Yun-mi
2019-11-07 16:10
AbbVie’s hepatitis C drug gets 8-week therapy regardless of cirrhosis
by Kim Yun-mi
2019-11-06 16:00
-
1
2
3
4
5
6
7
8
9
10
다음
-
176 civic groups furious over government-doctors deal
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
UBcare wins patent for tech to monitor suspected infectious diseases
SCM Lifescience punished for delaying adverse reaction report
176 civic groups furious over government-doctors deal
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
UBcare wins patent for tech to monitor suspected infectious diseases
SCM Lifescience punished for delaying adverse reaction report
여백
Most viewed
1
‘Cyramza helped improve gastric cancer treatment in Korea’
2
‘Reduced-dose prasugrel effective for ACS patients undergoing PCI’
3
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
4
SNUBH develops AI model predicting patients at risk of cerebral aneurysm
5
Novavax releases encouraging phase-1 results on Covid-19 vaccine candidate
6
LG Chem, SK Bioscience end sales partnership with Daewoong
7
UBcare wins patent for tech to monitor suspected infectious diseases
8
176 civic groups furious over government-doctors deal
9
Recovered Covid-19 patients suffer from aftereffects – for long
10
Regulator OKs JW Pharma's rheumarthritis drug for treating giant cell arteries
여백
Opinion
[Column] Correct diagnosis leads to proper treatment
[Column] How ongoing doctors’ strike is different from 20 years ago
A Korean-American Doctor asks: Is Korea truly in 2020?
여백
Back to Top